The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 22, 2011

Filed:

Feb. 10, 2011
Applicants:

Norbert Wild, Gereteried/Gelting, DE;

Veit Peter Grunert, Munich, DE;

Johann Karl, Peissenberg, DE;

Werner Zolg, Weilheim-Unterhausen, DE;

Inventors:

Norbert Wild, Gereteried/Gelting, DE;

Veit Peter Grunert, Munich, DE;

Johann Karl, Peissenberg, DE;

Werner Zolg, Weilheim-Unterhausen, DE;

Assignee:

Roche Diagnostics Operations, Inc., Indianapolis, IN (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/564 (2006.01); C07K 14/47 (2006.01); C07K 16/18 (2006.01);
U.S. Cl.
CPC ...
Abstract

Disclosed is a method for assessing a severity of rheumatoid arthritis. The method involves measuring in a patient sample a concentration of anti-cyclic citrullinated peptides (anti-CCP) and serum amyloid A, combining the concentrations determined to obtain a combined value, and comparing the combined value to a cut-off value established from a reference population. In another method, a marker selected from the group consisting of C-reactive protein (CRP), interleukin 6 (IL-6), S100 protein, osteopontin, rheumatoid factor (RF), matrix metalloprotease 1 (MMP-1), matrix metalloprotease 3 (MMP-3), hyaluronic acid, and soluble CD14 (sCD14) may also be determined along with the anti-CCP and serum amyloid A.


Find Patent Forward Citations

Loading…